-
Loading metrics
A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
- David Gardiner,
- Jay Lalezari,
- Eric Lawitz,
- Michael DiMicco,
- Rheem Ghalib,
- K. Rajender Reddy,
- Kyong-Mi Chang,
- Mark Sulkowski,
- Steven O’ Marro,
- Jeffrey Anderson
x
- Published: May 22, 2013
- https://doi.org/10.1371/journal.pone.0063818